2020 has been an extraordinarily challenging year for people, governments, and companies around the world. For biopharma multinational Amgen, which this year turns 40, and its Taiwan affiliate, now in its fifth year of operation on the island, 2020 has become a time for reflection. As different countries experience varying levels of disruption and negative…

Pfizer has called on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. “In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic,” Dr. Albert Bourla, the company’s Chairman and CEO, said in a statement. “Many companies, including Pfizer, are working…

Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub – Is Taiwan Ready for the Top Spot?” That provocative topic was the theme of a half-day conference – held April 25 at the Chang Yung-Fa Foundation’s International Convention Center – that featured a number of prominent expert speakers and panelists from both Taiwan and internationally. The…